Management of Urinary Tract Calculi: A Comprehensive Narrative Review of Contemporary Diagnosis, Classification, and Therapeutic Strategies
DOI:
https://doi.org/10.31004/joecy.v6i1.9504Keywords:
urolithiasis; nephrolithiasis; shock wave lithotripsy; ureteroscopy; percutaneous nephrolithotomy; medical expulsive therapy; renal calculi; stone managementAbstract
Background: Urinary tract calculi (urolithiasis) represent one of the most prevalent urological disorders worldwide, characterized by significant morbidity, high recurrence rates, and a rising global incidence. The disease spectrum encompasses stones forming anywhere from the renal pelvis to the urethra, presenting with a wide range of clinical manifestations including renal colic, hematuria, urinary tract infection, hydronephrosis, and impaired renal function.
Objective: This narrative review aims to comprehensively synthesize current evidence on the etiology, pathophysiology, classification, diagnostic workup, and therapeutic management of urinary tract calculi, with emphasis on contemporary minimally invasive interventional strategies.
Methods: A systematic literature search was conducted across PubMed, Scopus, and Web of Science databases using terms including 'urolithiasis,' 'nephrolithiasis,' 'renal calculi,' 'urinary stone management,' 'ESWL,' 'ureteroscopy,' and 'PCNL.' Articles published between 2020 and 2025, including clinical guidelines from the European Association of Urology (EAU) and the American Urological Association (AUA), were reviewed and synthesized.
Results: Urolithiasis affects approximately 1 in 11 individuals in Western populations, with a recurrence rate approaching 50% within five years. Calcium oxalate stones represent the majority (~80%), with uric acid, struvite, and cystine stones constituting the remainder. Pathogenesis involves urinary supersaturation, nucleation, crystal aggregation, and crystal-cell interactions. Diagnosis relies on non-contrast CT, which offers superior sensitivity and specificity. Management is guided by stone size, location, composition, degree of obstruction, and patient factors. Conservative management with medical expulsive therapy (MET) using alpha-blockers is effective for distal ureteral stones ≥5 mm. Active interventions include shock wave lithotripsy (SWL), ureteroscopy (URS), retrograde intrarenal surgery (RIRS), and percutaneous nephrolithotomy (PCNL). For stones >20 mm, PCNL remains the first-line treatment, while endourological advances have significantly reduced the need for open surgery.
Conclusions: Optimal management of urinary tract calculi requires an individualized, evidence-based approach incorporating stone characteristics, patient comorbidities, and available resources. Advances in endourology continue to improve stone-free rates while reducing morbidity. Long-term prevention through metabolic evaluation, dietary modification, and pharmacological prophylaxis is integral to reducing recurrence and improving patient quality of life.
References
Skolarikos A, Geraghty R, Somani B, Tailly T, Jung H, Neisius A, et al. European Association of Urology guidelines on the diagnosis and treatment of urolithiasis. Eur Urol. 2025;88(1):64–75.
Thakore P, Liang TH. Urolithiasis. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025.
Lu J, Gao W, Fei C, Liao W, Hou G, Lin Y, et al. Associated factors for benign prostatic hyperplasia in patients with bladder calculi. Urologia. 2025;3915603251318869.
Allam EA. Urolithiasis unveiled: pathophysiology, stone dynamics, types, and inhibitory mechanisms: a review. Afr J Urol. 2024;30(1):34.
Ahmed A, Rizvi N, Riaz MM, Ali SA, Asif M. Silodosin versus tamsulosin in medical expulsion therapy for lower ureteral calculi. Pak J Med Health Sci. 2023;17:423.
Yasui T, Okada A, Hamamoto S, Ando R, Taguchi K, Tozawa K. Pathophysiology-based treatment of urolithiasis. Int J Urol. 2022;29(4):276–285.
Wang Z, Zhang Y, Zhang J, Deng Q, Liang H. Recent advances in the mechanisms of kidney stone formation. Int J Mol Med. 2021;48:4982.
Shadman A, Bastani B. Kidney calculi: pathophysiology and systemic implications. Iran J Kidney Dis. 2021;15(3):161–170.
Aune D, Mahamat-Saleh Y, Norat T, Riboli E. Lifestyle factors and kidney stone risk: updated systematic review and meta-analysis. Eur J Epidemiol. 2022;37(9):903–917.
Espino-Grosso PM, Canales BK. Kidney stones after bariatric surgery: risk assessment and mitigation. Bariatr Surg Pract Patient Care. 2021;16(2):65–72.
Chung MJ. Urolithiasis and nephrolithiasis: contemporary management. JAAPA. 2021;34(9):35–41.
Singh KB, Sailo S. Epidemiology and etiologic factors of urolithiasis: recent perspectives. Sci Vis. 2021;21(2):89–97.
Wang CJ, Huang SW, Chang CH. Emergency decompression in obstructive urolithiasis with sepsis: current evidence. Urolithiasis. 2021;49(6):491–499.
Aboumarzouk OM, Somani BK, Monga M. Flexible ureteroscopy for large renal stones: updated systematic review. J Endourol. 2021;35(9):1201–1210.
Assimos D, Krambeck A, Miller NL, Monga M, Murad MH, Nelson CP. Surgical management of stones: guideline update. J Urol. 2022;208(6):1156–1165.
El-Nahas AR, Sheir KZ. Predictors of success of shock wave lithotripsy: updated review. World J Urol. 2021;39(6):1917–1925.
Inci K, Sahin A, Ozen H. Natural history of asymptomatic renal stones: recent evidence. Curr Opin Urol. 2022;32(2):89–94.
Ma Q, Fang L, Su R, Ma L, Xie G, Cheng Y. Uric acid stones: clinical features and therapeutic strategies. Postgrad Med J. 2021;97(1147):458–464.
Sellaturay S, Fry C. Metabolic evaluation of urolithiasis: current concepts. Surgery. 2021;39(4):185–192.
Ratkalkar VN, Kleinman JG. Advances in understanding kidney stone pathogenesis. Nat Rev Nephrol. 2021;17(8):507–521.
Evan AP, Lingeman JE. Randall plaque and calcium stone formation: updated insights. Urolithiasis. 2021;49(1):17–26.
Trinchieri A. Epidemiology of urolithiasis: modern trends. Urolithiasis. 2022;50(1):3–10.
Engeler DS, Baranowski AP. Analgesic management of acute renal colic: current recommendations. Scand J Urol. 2021;55(3):165–171.
Noegroho BS, Daryanto B, Soebadi DM. Indonesian clinical practice guideline on urolithiasis: update. Acta Med Indones. 2022;54(3):345–357.
Wang Z, Deng Q, Zhang J. Inflammation and crystal adhesion in kidney stone disease. Front Immunol. 2022;13:845726.
Olszya MJ, Gower LB. Biomineralization and kidney stone formation: recent concepts. Crystals. 2021;11(9):1045.
Yasui T, Taguchi K, Hamamoto S. Prevention of stone recurrence: evidence-based strategies. Int J Urol. 2023;30(1):3–12.
Geraghty RM, Jones P, Somani BK. Worldwide trends in endourological management of urolithiasis. World J Urol. 2023;41(2):337–346.
Tailly T, Skolarikos A. Future directions in urolithiasis management. Eur Urol Focus. 2024;10(1):15–22.
Krum H, et al. NSAIDs and renal outcomes in acute pain management. Cardiovasc Ther. 2021;39(2):e12283.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Abdullah Abdullah, Muhammad Chairi Situmorang, Maimun Syukri, Maimun Syukri, Desi Salwani

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.







